Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_04231
Species: Homo sapiens
Position : chr2:16370000-16380000
Year: 2020
Title: Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastoma.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: neuroblastoma
PMID:  33199677
MONDO: MONDO:0005072
Tissue: adrenal gland
Tissue Ontology ID: UBERON:0002369
Cell Source: Kelly
CVCL ID: CVCL_2092
Cell Type: neuroblastoma cell
Experiment Type: Enhancer activity assay, TF binding assay, Chromatin interaction assay
High Throughput Method: ChIP-seq; RNA-seq; ATAC-seq, 3C-seq; ATAC-seq; Hi-C; Oxford Nanopore sequencing
Low Throughput Method: qRT-PCR, and ChIP-qPCR
About Target Gene
Target gene : MYCN
About TF
TF name : GATA3
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
GATA3 C-MYB transcription factor network pid 87
GATA3 Calcineurin-regulated NFAT-dependent transcription in lymphocytes pid 50
GATA3 Factors involved in megakaryocyte development and platelet production reactome 111
GATA3 Glucocorticoid receptor regulatory network pid 85
GATA3 IL27-mediated signaling events pid 26
GATA3 Notch signaling pathway pid 58
GATA3 Regulation of nuclear SMAD2/3 signaling pid 82
GATA3 Hs_Endochondral_Ossification_WP474_87977 wikipathways 43
GATA3 Hs_White_fat_cell_differentiation_WP3946_90940 wikipathways 30
Enhancer Associated Network
Overlapping Enhancers (hg19) 2 found
Enhancer ID Position Tissue Cell Disease
E_04232 chr2:16370000-16380000 adrenal gland neuroblastoma cell neuroblastoma
E_04233 chr2:16370000-16380000 adrenal gland neuroblastoma cell neuroblastoma
Expression of Target Genes for the Enhancer